Molecular biology of pituitary neuroendocrine tumors. Read more about Molecular biology of pituitary neuroendocrine tumors.
Correction to: Preoperative assessment of tumor eloquence and resectability: an international survey. Read more about Correction to: Preoperative assessment of tumor eloquence and resectability: an international survey.
NOTCH3 drives fatty acid oxidation and ferroptosis resistance in aggressive meningiomas. Read more about NOTCH3 drives fatty acid oxidation and ferroptosis resistance in aggressive meningiomas.
Takeaways from meta-analysis: indications of combinational treatments for glioblastoma. Read more about Takeaways from meta-analysis: indications of combinational treatments for glioblastoma.
Preoperative assessment of tumor eloquence and resectability: an international survey. Read more about Preoperative assessment of tumor eloquence and resectability: an international survey.
Simulation tools in neuro-oncological surgery: a scoping review of perioperative and training applications. Read more about Simulation tools in neuro-oncological surgery: a scoping review of perioperative and training applications.
Current clinical trials for craniopharyngiomas: what's on the horizon? Read more about Current clinical trials for craniopharyngiomas: what's on the horizon?
The association between postoperative photon radiotherapy dose and disease control and salvage treatment in pediatric and adolescent ependymoma: a multi-institutional investigation. Read more about The association between postoperative photon radiotherapy dose and disease control and salvage treatment in pediatric and adolescent ependymoma: a multi-institutional investigation.
Sonodynamic therapy with a single neoadjuvant, diffuse delivery of low-intensity ultrasound with 5-ALA in treatment naïve glioblastoma results in tumor-specific cytotoxic edema and increased apoptosis. Read more about Sonodynamic therapy with a single neoadjuvant, diffuse delivery of low-intensity ultrasound with 5-ALA in treatment naïve glioblastoma results in tumor-specific cytotoxic edema and increased apoptosis.
A phase I study of convection-enhanced delivery (CED) of liposomal-irinotecan using real-time magnetic resonance imaging in patients with recurrent high-grade glioma. Read more about A phase I study of convection-enhanced delivery (CED) of liposomal-irinotecan using real-time magnetic resonance imaging in patients with recurrent high-grade glioma.
